世界の恥骨上カテーテル市場の規模、シェア、トレンド分析レポート – 業界の概要と2031年までの予測

恥骨上カテーテル市場分析

腹部から膀胱に挿入されるカテーテルに重点を置く恥骨上カテーテル市場は、低侵襲性泌尿器科手術の需要の高まりにより拡大しています。成長の原動力には、泌尿器科疾患の増加、人口の高齢化、カテーテルの設計と材料の進歩、快適性と患者の転帰の改善などがあります。最近の開発には、感染率の低下を目的とした抗菌コーティングカテーテルと生体適合性材料があります。治療費の高さや閉塞などの潜在的な合併症などの課題にもかかわらず、恥骨上カテーテル市場は、これらの手術の継続的な進歩と採用の増加により、着実な成長が見込まれています。

恥骨上カテーテル市場規模

世界の恥骨上カテーテル市場規模は、2023年に174億7,000万米ドルと評価され、2024年から2031年の予測期間中に6.54%のCAGRで成長し、2031年までに290億米ドルに達すると予測されています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

恥骨上カテーテル市場の動向

「抗菌コーティングの革新」

恥骨上カテーテル市場は、特に膀胱機能不全や尿閉の患者に対する低侵襲性尿ソリューションの需要の高まりに牽引されて成長を遂げています。抗菌コーティングや生体適合性材料などのカテーテル設計の革新により、患者の快適性が向上し、感染リスクが軽減され、これらのデバイスは臨床現場でより魅力的になっています。重要な傾向は、院内感染を最小限に抑え、患者の転帰を改善することを目的とした抗菌コーティングされた恥骨上カテーテルの採用が増えていることです。さらに、世界人口の高齢化と泌尿器疾患の有病率の増加が需要を刺激しています。材料の進歩と患者の安全性への重点により、恥骨上カテーテル市場は着実な成長を遂げ、信頼性が高くより安全な尿ケアソリューションを求める医療従事者と患者の両方のニーズに対応しています。

レポートの範囲と恥骨上カテーテル市場のセグメンテーション

Suprapubic Catheter Market Definition

A suprapubic catheter is a type of urinary catheter inserted through a small incision in the abdomen, just above the pubic bone, directly into the bladder to drain urine. This catheterization method is often used for patients who cannot use traditional urethral catheters due to blockages, injuries, or long-term conditions. Suprapubic catheters are typically preferred for extended use, as they reduce the risk of urinary tract infections and provide a more comfortable option for managing urinary retention or bladder dysfunction.

Suprapubic Catheter Market Dynamics

Drivers

• Rising Prevalence of Urinary Incontinence

The rising prevalence of conditions such as urinary incontinence, benign prostatic hyperplasia device (BPH), and bladder dysfunction is significantly fueling the demand for suprapubic catheters as effective management solutions. Urinary incontinence affects millions of individuals, particularly among the aging population, leading to a growing need for reliable urinary drainage options. BPH, a common condition in older men, often necessitates catheterization for relief from urinary obstruction. Additionally, various bladder dysfunctions, resulting from neurological disorders or other health issues, require consistent monitoring and management. As healthcare providers seek safer and more effective options for these conditions, suprapubic catheters are increasingly recognized as a viable choice, driving market growth.

• Rising Healthcare Expenditures

Increased healthcare spending, particularly in emerging markets, plays a crucial role in supporting investments in advanced medical devices, including suprapubic catheters. As governments and private sectors allocate more funds toward healthcare infrastructure, there is a notable emphasis on enhancing medical technology and improving patient care. This trend is driven by a rising awareness of the importance of effective urinary management solutions, particularly in regions experiencing a surge in urological disorders. As a result, manufacturers are encouraged to innovate and expand their product offerings. The availability of advanced suprapubic catheters aligns with the growing demand for safer, more effective treatment options, thereby propelling market growth.

Opportunities

• Integrating Telemedicine Solutions and Remote Monitoring

Integrating telemedicine solutions and remote monitoring technologies with suprapubic catheter management represents a significant market opportunity that can enhance patient outcomes and adherence. By utilizing telehealth platforms, healthcare providers can offer real-time monitoring of catheter use, enabling timely interventions when issues arise, such as blockages or infections. This proactive approach improves patient safety and fosters better communication between patients and their healthcare teams. Additionally, remote monitoring allows for more personalized care plans, tailored to individual patient needs, which can lead to improved satisfaction and compliance. As healthcare increasingly embraces digital solutions, the combination of telemedicine and suprapubic catheters will likely become a preferred model, further driving market growth.

• Innovations in Catheter Design

The development of antimicrobial coatings significantly reduces the risk of catheter-associated infections, addressing one of the primary concerns associated with urinary catheterization. Additionally, the use of biocompatible materials minimizes irritation and discomfort for patients, improving their overall experience. As these innovations make suprapubic catheters more reliable and user-friendly, healthcare providers are more likely to integrate them into their treatment protocols. This growing acceptance can lead to increased sales and market share for manufacturers committed to advancing catheter technology.

Restraints/Challenges

• Competition from Alternative Solutions

The availability of various urinary management options, including intermittent catheters and external devices, presents a significant challenge to the suprapubic catheter market. Healthcare providers may favor these alternatives due to perceptions of safety and ease of use. Intermittent catheters, for instance, are often associated with lower infection rates and can be self-administered by patients, promoting autonomy and reducing reliance on healthcare facilities. Additionally, external devices, such as condom catheters, offer a non-invasive solution that may be preferred by both patients and providers. This competitive landscape makes it essential for suprapubic catheter manufacturers to emphasize the unique benefits of their products, addressing concerns and enhancing their market positioning.

•  High Treatment Costs of Surgery

The expenses associated with suprapubic catheter insertion and ongoing management represent a significant restraint for the market, particularly in resource-limited settings. The initial costs of the procedure, including surgical supplies and personnel, can be substantial, deterring healthcare providers from adopting these solutions. Furthermore, the need for regular monitoring and potential complications, such as infections or catheter blockages, can lead to additional healthcare expenditures. In environments where budgets are constrained, providers may prioritize more cost-effective alternatives, limiting the market potential for suprapubic catheters. As a result, addressing these financial barriers is crucial for fostering wider acceptance and utilization of these devices.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Suprapubic Catheter Market Scope

The market is segmented on the basis of product type, indication, material, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Free Drainage Catheters
• Valve Catheters

Indication

• Benign Prostate Hyperplasia
• Urinary Incontinence
• Others

Material

• Rubber
• Plastic
• Polyvinyl Chloride

End User

• Hospitals
• Ambulatory Surgical Centers
• Urology Surgical Centers
• Others

Suprapubic Catheter Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, indication, material, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is the leading region in the suprapubic catheter market, driven by a significant rise in urology patient populations. The region boasts a highly advanced healthcare infrastructure and a consistent, favorable reimbursement landscape in both the U.S. and Canada. These factors collectively enhance access to suprapubic catheterization and contribute to the market's robust growth.

Asia-Pacific region is projected to experience substantial growth in the suprapubic catheter market during the forecast period from 2024 to 2031, primarily due to the high prevalence of chronic diseases. This rising incidence of health conditions requiring effective urinary management solutions is driving demand for suprapubic catheters. Additionally, increasing healthcare investments and improving infrastructure in the region are expected to further support market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Suprapubic Catheter Market Share

市場競争環境では、競合他社ごとの詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などが含まれます。提供される上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。

恥骨上カテーテル市場のリーダー企業は以下の通りです。

• B.ブラウンSE（ドイツ）
• アメカト（エジプト）
• ウロテック（ドイツ）
• BD（米国）
• クック（米国）
• ウロビジョン・ウロテック（ドイツ）
• テレフレックス株式会社（米国）
• Endotherapeutics Pty Ltd. (オーストラリア)
• pfm medical gmbh.（ドイツ）
• フォーチュンメディカルインストゥルメントコーポレーション（台湾）
• サルヴァヴィダス（インド）
• EBSCO Industries, Inc. (米国)
• シグナグループ（米国）
• マケソンメディカルサージカル社（米国）
• バイタリティメディカル社（米国）
• マニッシュ・メディ・イノベーション（インド）
• アドビン泌尿器科（インド）
• メディプラスインディア株式会社（インド）
• UROMED Kurt Drews KG (ドイツ)

恥骨上カテーテル市場の最新動向

• 2020年2月、Levity Productsは、特に恥骨上カテーテル用に設計された、新たに特許を取得した外部カテーテルスタビライザーのシリーズを発表しました。これらの革新的なスタビライザーは、従来の方法に関連する一般的な懸念に対処するために、カテーテル配置の快適性と安全性を高めることを目的としています。患者の体験を改善し、合併症のリスクを軽減することで、この製品の発売はカテーテル管理ソリューションの大きな進歩を表しています。
• 2021年3月、メディプラスは、同社の恥骨上カテーテルシステムがテキサス州の介入放射線科医によって利用されることを発表しました。この採用は、これらの専門医の尿路疾患管理能力を高めるための重要な一歩となります。この高度なカテーテルシステムを統合することで、メディプラスは、この地域での患者の転帰を改善し、手順の効率を合理化することを目指しています。

SKU-59182